Back
MicroSectors FANG+ Index 3X Leveraged ETN Vs. Novo Nordisk AS Industry Stock Comparison
Buy
65
FNGU
MicroSectors FANG+ Index 3X Leveraged ETN
Last Price:
$593.00
Seasonality Move:
28.11%
Sell
29
NVO
Novo Nordisk AS
Last Price:
$87.54
Seasonality Move:
6.4%
Buy
65
MicroSectors FANG+ Index 3X Leveraged ETN (FNGU)
is a Buy
Is MicroSectors FANG+ Index 3X Leveraged ETN a Buy, Sell or Hold?
-
The current MicroSectors FANG+ Index 3X Leveraged ETN [FNGU] share price is $583.59. The Score for FNGU is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
FNGU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $86.02. The Score for NVO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FNGU Stock Price Chart
What is MicroSectors FANG+ Index 3X Leveraged ETN's stock price today?
-
The MicroSectors FANG+ Index 3X Leveraged ETN share price today is $583.59The current trend is moderately bearish and FNGU is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $86.02Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
FNGU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 26.45 | Buy |
Relative Strength Index (14 RSI): | 48.93 | Sell |
Chaikin Money Flow: | -638185 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (531.29 - 643.85) | Sell |
Bollinger Bands (100): | (375.78 - 552.58) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.1 | Sell |
Relative Strength Index (14 RSI): | 26.04 | Sell |
Chaikin Money Flow: | 3954400 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (92.37 - 111.71) | Sell |
Bollinger Bands (100): | (102.88 - 130.98) | Sell |
FNGU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 617.07 | Sell |
20-day SMA: | 608.14 | Sell |
50-day SMA: | 532.55 | Buy |
200-day SMA: | 418.75 | Buy |
8-day EMA: | 617.14 | Sell |
20-day EMA: | 600.68 | Sell |
50-day EMA: | 546.36 | Buy |
200-day EMA: | 427.24 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.91 | Sell |
20-day SMA: | 100.93 | Sell |
50-day SMA: | 105.5 | Sell |
200-day SMA: | 124.86 | Sell |
8-day EMA: | 90.16 | Sell |
20-day EMA: | 97.16 | Sell |
50-day EMA: | 105.13 | Sell |
200-day EMA: | 116.29 | Sell |
MicroSectors FANG+ Index 3X Leveraged ETN Earnings Growth & FNGU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
MicroSectors FANG+ Index 3X Leveraged ETN Technical Analysis
Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
16 | 17 | 18 | 19 | 20 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |